| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4434d9c0e5f1b37787bcf6d2a240979d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_212d16e083262e5a3f24e2a7a03d6d56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_764856a004a50a101e2f526a5dec6f3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9548f48f14d4d3caa5fae99eed7b580
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_686ac97b086ddaff2cbcc60349621dc0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fb89d4054d5dd07fe6d73c7b89d367a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2821
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2009-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b947ba9e555e51426ea4c493cb3f7d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_346ce7a9632293e6f6f0e4714e2921f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a246bbe17ed47d7de30c2280ad7be0a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b69f57dc48143384f01962eb31af90c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9a7b41760c5f2aabc342055fd0b7b45 |
| publicationDate |
2010-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010016652-A1 |
| titleOfInvention |
Antibody modulating the differentiation and function of dendritic cells via binding intercellular adhesion molecule-1 and use thereof |
| abstract |
The present invention relates to an antibody binding to human intercellular adhesion molecule-1 (ICAM-1) where the antibody is able to modulate the differentiation status of dendritic cells and prolong the graft survival. In addition, the present invention provides a pharmaceutical composition comprising the antibody, and method of using them for the treatment of disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2789757-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3909979-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11084876-B2 |
| priorityDate |
2008-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |